Amalus Therapeutics

Amalus Therapeutics

Foundation date

13/07/2023

Sector

#Biotechnology - Therapeutics

Subsector

• #Therapeutics - Small molecules

Therapeutic areas

• #Neoplasms / cancer / oncology

Amalus Therapeutics convert the power of selective fibroblast modulation into transformative therapeutics. Pathologically activated fibroblasts orchestrate abnormal tissue structure and drive many diseases. Our technology modulates of disease-associated fibroblasts with unprecedented selectivity, resulting in precise tissue remodeling and normalization, and generating multiple therapeutic benefits.

Our mission is to profoundly reshape the lives of people affected by cancer and fibrotic diseases.